Drug intelligence / Profile preview

Mucinex Full Force Nasal Spray

Development stage
Phase 4
Lead developer
Reckitt
Modality
Small Molecules
Administration
Intranasal
01

Overview

Mucinex Full Force Nasal Spray (also marketed as Mucinex Sinus-Max Full Force) is an over-the-counter topical nasal decongestant developed by Reckitt Benckiser. The active ingredient is oxymetazoline hydrochloride (0.05%), a small molecule sympathomimetic amine that acts as an agonist on alpha-adrenergic receptors. By stimulating these receptors in the nasal mucosa, the drug induces vasoconstriction of dilated arterioles, which reduces blood flow and swelling in the nasal passages. It is indicated for the temporary relief of nasal and sinus congestion and pressure associated with the common cold, hay fever, and other upper respiratory allergies. The formulation provides rapid onset of action with effects lasting up to 12 hours and includes a cooling menthol sensation.

Brand names
Mucinex Full Force Nasal SprayMucinex Sinus-Max Full Force
Other names
oxymetazoline hydrochloride 0.05% nasal spray
02

Targets

ADRA1A (α1A)ADRA2A (α2A)

Beyond the preview

Go deeper on Mucinex Full Force Nasal Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucinex Full Force Nasal Spray.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call